Search results
Bristol Myers (BMY) Gets EC Nod for Abecma's Label Expansion
Zacks via Yahoo Finance· 3 months agoBristol Myers (BMY) wins European Commission's approval for the label expansion of its CAR T cell...
Is Exelixis' (EXEL) Growth Story Likely to Continue?
Zacks via Yahoo Finance· 2 years agoExelixis EXEL, an oncology-focused company, maintains momentum on the back of the solid performance of its lead drug Cabometyx amid stiff competition...
Q4 2023 Esperion Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Alexis Callahan; IR; Esperion Therapeutics, Inc. Sheldon Koenig; President & CEO; Esperion Therapeutics, Inc. Ben Halladay; CFO; Esperion Therapeutics, Inc. Eric Warren; Chief Commercial ...
Exelixis (EXEL) Reports Data from CONTACT-01, QUARTZ-101 Study
Zacks via Yahoo Finance· 1 year agoExelixis (EXEL) announces that the phase III study, CONTACT-01, did not meet its primary endpoint....
Exelixis (EXEL) Begins Study on XL092 Combo in Colorectal Cancer
Zacks via Yahoo Finance· 2 years agoExelixis (EXEL) starts the phase III STELLAR-303 study evaluating XL092 in combination with...
Is This Chinese Pharmaceutical Stock Worth the Risk?
Motley Fool· 2 years agoBeiGene (NASDAQ: BGNE), is a Chinese biopharmaceutical company with offices in Cambridge, Massachusetts; Basel, Switzerland; and Beijing. It focuses on...
